IceCure Medical (ICCM) News Today $0.95 +0.01 (+0.76%) Closing price 06/18/2025 03:56 PM EasternExtended Trading$0.96 +0.01 (+1.37%) As of 09:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICCM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period IceCure Medical (NASDAQ:ICCM) Trading Up 0.8% - Should You Buy?June 19 at 1:55 AM | americanbankingnews.comIceCure Medical (NASDAQ:ICCM) Trading Up 0.8% - Here's What HappenedIceCure Medical (NASDAQ:ICCM) Trading Up 0.8% - What's Next?June 19 at 1:52 AM | marketbeat.comIceCure Medical: IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient OutcomesJune 10, 2025 | finanznachrichten.deIceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient OutcomesJune 9, 2025 | prnewswire.comHC Wainwright Reiterates "Buy" Rating for IceCure Medical (NASDAQ:ICCM)HC Wainwright reiterated a "buy" rating and issued a $2.50 target price on shares of IceCure Medical in a report on Thursday.May 30, 2025 | marketbeat.comIcecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Strategic Advances and Market ...May 29, 2025 | finance.yahoo.comIceCure Medical (NASDAQ:ICCM) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPSIceCure Medical (NASDAQ:ICCM - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.02. IceCure Medical had a negative return on equity of 124.44% and a negative net margin of 376.85%. During the same period in the prior year, the firm posted ($0.08) EPS.May 29, 2025 | marketbeat.comIceCure Medical Ltd (NASDAQ:ICCM) Q1 2025 Earnings Call TranscriptMay 29, 2025 | insidermonkey.comIceCure Medical Ltd (ICCM) Q1 2025 Earnings Call TranscriptMay 28, 2025 | seekingalpha.comIceCure (ICCM) Q1 2025 Earnings Call TranscriptMay 28, 2025 | msn.comIceCure Medical Reports First Quarter 2025 Financial ResultsMay 28, 2025 | prnewswire.comEarnings Preview For Icecure MedicalMay 27, 2025 | benzinga.comIceCure Medical (ICCM) Expected to Announce Earnings on TuesdayIceCure Medical (NASDAQ:ICCM) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 27. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-27-icecure-medical-ltd-stock/)May 22, 2025 | marketbeat.comIceCure Medical Secures $2 Million Bridge Loan from EpochMay 21, 2025 | tipranks.comIceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025May 21, 2025 | prnewswire.comFY2025 EPS Estimate for IceCure Medical Raised by AnalystIceCure Medical Ltd (NASDAQ:ICCM - Free Report) - Stock analysts at Brookline Capital Management increased their FY2025 earnings per share estimates for shares of IceCure Medical in a report issued on Monday, May 5th. Brookline Capital Management analyst K. Dolliver now anticipates that the compaMay 10, 2025 | marketbeat.comIceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® CryoablationMay 6, 2025 | prnewswire.comIceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast CancerApril 30, 2025 | prnewswire.comIceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging SymposiumApril 28, 2025 | prnewswire.comIceCure Medical (NASDAQ:ICCM) Shares Down 3.1% - Time to Sell?IceCure Medical (NASDAQ:ICCM) Trading Down 3.1% - Here's What HappenedApril 23, 2025 | marketbeat.comIceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer CryoablationApril 22, 2025 | prnewswire.comFY2027 EPS Estimates for IceCure Medical Reduced by AnalystIceCure Medical Ltd (NASDAQ:ICCM - Free Report) - Stock analysts at Brookline Capital Management reduced their FY2027 EPS estimates for IceCure Medical in a research report issued on Thursday, March 27th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will postMarch 31, 2025 | marketbeat.comShort Interest in IceCure Medical Ltd (NASDAQ:ICCM) Drops By 52.3%IceCure Medical Ltd (NASDAQ:ICCM - Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 285,500 shares, a decrease of 52.3% from the February 28th total of 598,100 shares. Currently, 1.0% of the company's stock are short sold. Based on an average daily trading volume, of 378,700 shares, the days-to-cover ratio is currently 0.8 days.March 29, 2025 | marketbeat.comIceCure Medical (NASDAQ:ICCM) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPSIceCure Medical (NASDAQ:ICCM - Get Free Report) announced its earnings results on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.01). The company had revenue of $1.07 million for the quarter, compared to the consensus estimate of $1.07 million. IceCure Medical had a negative return on equity of 124.44% and a negative net margin of 376.85%.March 29, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)HC Wainwright reissued a "buy" rating and issued a $2.50 price objective on shares of IceCure Medical in a report on Friday.March 29, 2025 | marketbeat.comIceCure Medical Ltd (NASDAQ:ICCM) Q4 2024 Earnings Call TranscriptMarch 28, 2025 | insidermonkey.comIceCure Medical Ltd’s Earnings Call: Growth Amidst ChallengesMarch 27, 2025 | tipranks.comIceCure Medical Ltd (ICCM) Q4 2024 Earnings Call TranscriptMarch 27, 2025 | seekingalpha.comIceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense Cryoablation Sales in North AmericaMarch 27, 2025 | finanznachrichten.deEarnings Outlook For Icecure MedicalMarch 27, 2025 | benzinga.comIceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North AmericaMarch 27, 2025 | prnewswire.comIceCure Medical announces interim results from ICESECRET studyMarch 25, 2025 | markets.businessinsider.comIceCure Medical (ICCM) Projected to Post Earnings on ThursdayIceCure Medical (NASDAQ:ICCM) will be releasing earnings before the market opens on Thursday, March 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=677083)March 25, 2025 | marketbeat.comIceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free RateMarch 24, 2025 | prnewswire.comIceCure Medical in discussions with FDA on marketing request for ProSenseMarch 21, 2025 | markets.businessinsider.comIceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025March 21, 2025 | prnewswire.comIceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast CancerMarch 20, 2025 | prnewswire.comIceCure Medical Ltd (NASDAQ:ICCM) Short Interest UpdateIceCure Medical Ltd (NASDAQ:ICCM - Get Free Report) saw a large drop in short interest in February. As of February 28th, there was short interest totalling 598,100 shares, a drop of 22.7% from the February 13th total of 773,300 shares. Currently, 2.1% of the shares of the stock are short sold. Based on an average daily volume of 385,300 shares, the short-interest ratio is presently 1.6 days.March 18, 2025 | marketbeat.comIceCure Medical: IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation TechnologyMarch 18, 2025 | finanznachrichten.deIceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer ConferenceMarch 18, 2025 | prnewswire.comIceCure Medical receives Notice of Allowance from CNIPAMarch 17, 2025 | markets.businessinsider.comIceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation TechnologyMarch 17, 2025 | prnewswire.comIceCure Medical (NASDAQ:ICCM) Trading Down 4.4% - Time to Sell?IceCure Medical (NASDAQ:ICCM) Trading Down 4.4% - Time to Sell?March 11, 2025 | marketbeat.comBreast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care SurgeryMarch 10, 2025 | prnewswire.comIceCure Medical files for regulatory approval of cryoablation system in IsraelFebruary 24, 2025 | markets.businessinsider.comIceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in IsraelFebruary 24, 2025 | prnewswire.comIceCure Medical Ltd (NASDAQ:ICCM) Sees Large Decline in Short InterestIceCure Medical Ltd (NASDAQ:ICCM - Get Free Report) was the target of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 802,800 shares, a drop of 9.2% from the January 15th total of 883,900 shares. Based on an average daily volume of 607,200 shares, the days-to-cover ratio is presently 1.3 days. Currently, 3.3% of the company's stock are short sold.February 18, 2025 | marketbeat.comIceCure Medical Ltd's (NASDAQ:ICCM) Profit OutlookFebruary 18, 2025 | finance.yahoo.comIceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization DecisionFebruary 4, 2025 | prnewswire.comIceCure Medical files for approval of ProSense Cryoablation System in ChinaJanuary 28, 2025 | markets.businessinsider.com Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address ICCM Media Mentions By Week ICCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICCM News Sentiment▼0.000.68▲Average Medical News Sentiment ICCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICCM Articles This Week▼22▲ICCM Articles Average Week Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVRO News SGHT News DRTS News TLSI News BWAY News SKIN News AVR News LAKE News INGN News PROF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICCM) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredWar-Proof Power Why This "Weird" Government Land Auction Was No Ordinary Sale When 218,000 acres of land... smack in the m...Stansberry Research | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
